Targeting key proximal drivers of type 2 inflammation in disease
Regeneron (United States) · Sanofi (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
739
total citations
- FWCI
- 16.77
- Percentile
- 100%
- References
- 157
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Medicine
- Asthma
- Immunology
- Atopic dermatitis
- Inflammation
- Population
- Disease
- Immunoglobulin E
No related works found for this paper.